HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contact Dermatitis (Eczema, Contact)

A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.
Also Known As:
Eczema, Contact; Dermatitis, Contact; Contact Dermatitides; Contact Eczema; Contact Hypersensitivities; Contact Hypersensitivity; Contact Sensitivities; Contact Sensitivity; Dermatitides, Contact; Hypersensitivities, Contact; Sensitivities, Contact; Dermatitis Venenata; Hypersensitivity, Contact; Sensitivity, Contact
Networked: 8086 relevant articles (154 outcomes, 577 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Atopic Dermatitis (Atopic Eczema)
2. Hypersensitivity (Allergy)
3. Allergic Contact Dermatitis
4. Inflammation (Inflammations)
5. Eczema

Experts

1. Maibach, Howard I: 86 articles (11/2022 - 02/2002)
2. Sasseville, Denis: 85 articles (11/2022 - 11/2002)
3. Belsito, Donald V: 78 articles (11/2022 - 02/2002)
4. Fowler, Joseph F: 73 articles (11/2022 - 02/2002)
5. Warshaw, Erin M: 72 articles (11/2022 - 09/2004)
6. Taylor, James S: 71 articles (11/2022 - 02/2002)
7. Zug, Kathryn A: 66 articles (11/2022 - 01/2007)
8. Pratt, Melanie D: 64 articles (11/2022 - 02/2002)
9. DeLeo, Vincent A: 55 articles (11/2022 - 12/2004)
10. Marks, James G: 52 articles (11/2022 - 02/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Contact Dermatitis:
1. Irritants (Vesicants)IBA
01/01/2020 - "cerevisiae, we previously investigated the efficacy of heat-killed whole DGLA-producing yeast cells on irritant contact dermatitis, and showed that oral intake of this yeast significantly suppressed inflammatory reactions, whereas no such suppression was observed by the intake of 25 times the amount of purified DGLA. "
07/01/2016 - "No significant differences were found between baseline and week 104 in v-TAHC in Group 1 as well as f-TAHC, v-TAHC, f-TAHW and v-TAHW values in Group 2. 5% MTF is effective in stabilizing hair density, hair width and scalp coverage in both frontotemporal and vertex areas over an application period of 104 weeks, while showing a good safety and tolerability profile with a low rate of irritant contact dermatitis."
01/01/1992 - "Knowledge of determinants of skin susceptibility may be useful for the identification of high-risk subjects for development of irritant contact dermatitis, and may help to prevent the formation of the disease."
05/01/2018 - "These results suggest that the combination of these anti-irritating actives may possibly be effective in mitigating irritant contact dermatitis caused by other dermatological vehicles containing irritating agents, but further research is warranted to assess their effects."
11/01/2016 - "In these subjects prone to occupational irritant contact dermatitis, the hand protectant cream applied during the initial 7-day period was effective in restoring the damaged skin barrier and improving the stratum corneum hydration. "
2. AllergensIBA
3. Adrenal Cortex Hormones (Corticosteroids)IBA
4. HaptensIBA
5. Dinitrochlorobenzene (DNCB)IBA
6. Ointments (Pastes)IBA
7. Sunscreening Agents (Sunscreens)IBA
8. DinitrofluorobenzeneIBA
9. OxazoloneIBA
10. AntigensIBA

Therapies and Procedures

1. Therapeutics
2. Intraperitoneal Injections
3. Skin Care
4. Oral Administration
5. Hypophysectomy